Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
10/02/2002 | EP1244629A2 Quinolone compounds for use in treating viral infections |
10/02/2002 | EP1244626A2 Caspase inhibitors and uses thereof |
10/02/2002 | EP1244611A1 Squaric acid derivatives as integrin antagonists |
10/02/2002 | EP1244453A1 Method and composition for the treatment of pain |
10/02/2002 | EP1244434A2 Use of chemotherapeutic agents |
10/02/2002 | EP1129091B1 Crf receptor antagonists and methods relating thereto |
10/02/2002 | EP1098894B1 Fkbp inhibitors |
10/02/2002 | EP0843675B1 Aza-anthracyclinone derivatives |
10/02/2002 | EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia |
10/02/2002 | EP0715628B1 Substituted azaindolylidene compounds and process for their preparation |
10/02/2002 | EP0706521B1 Imides as tnf alpha inhibitors |
10/02/2002 | CN1372558A Intermediates for the production of quinolone carboxylic acid derivatives |
10/02/2002 | CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof |
10/02/2002 | CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands |
10/02/2002 | CN1091770C Compounds useful as antiproliferative agents and GARFT inhibitors |
10/02/2002 | CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
10/02/2002 | CN1091595C Use of a compound in preparing medicine for curing dyspepsia |
10/01/2002 | US6458954 Process for preparing piperidines |
10/01/2002 | US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, |
10/01/2002 | US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer |
10/01/2002 | US6458800 1,2-annelated quinoline derivatives |
10/01/2002 | US6458784 Vitronectin receptor antagonists |
10/01/2002 | CA2228370C Piperazino derivatives as neurokinin antagonists |
10/01/2002 | CA2089769C Heterocyclic compounds and their preparation and use |
10/01/2002 | CA2063926C Imidazopyridine |
09/26/2002 | WO2002074910A2 Selective anti-viral nucleoside chain terminators |
09/26/2002 | WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use |
09/26/2002 | WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient |
09/26/2002 | WO2002074769A1 Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient |
09/26/2002 | WO2002074767A1 Metalloproteinase inhibitors |
09/26/2002 | WO2002074765A1 Phenyl derivatives 3 |
09/26/2002 | WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
09/26/2002 | WO2002074753A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
09/26/2002 | WO2002074751A1 Metalloproteinase inhibitors |
09/26/2002 | WO2002074750A1 Metalloproteinase inhibitors |
09/26/2002 | WO2002074748A1 Metalloproteinase inhibitors |
09/26/2002 | WO2002074342A1 Remedies for arteriosclerosis |
09/26/2002 | WO2002062796A8 Epindolidione pigments |
09/26/2002 | WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof |
09/26/2002 | WO2002060382A3 Novel compounds and uses thereof |
09/26/2002 | WO2002040484A3 Novel imidazole derivatives, production method thereof and use thereof |
09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
09/26/2002 | WO2002024685A8 Indole derivatives and their use as antifungal and/or antiparasitic agents |
09/26/2002 | WO2001019823A9 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
09/26/2002 | WO2000043375A3 Substituted aryl heterocyclic compounds |
09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
09/26/2002 | US20020137939 Novel guanidinobenzamides |
09/26/2002 | US20020137935 3-Substituted 2,7-naphthyridin-1-yl derivatives |
09/26/2002 | US20020137765 Sustained release formulations for growth hormone secretagogues |
09/26/2002 | US20020137763 (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione |
09/26/2002 | US20020137756 7-oxo-pyridopyrimidines (I) |
09/26/2002 | US20020137741 Use as topical antibiotics |
09/26/2002 | US20020137738 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
09/26/2002 | US20020137664 Substituted piperidines as melanocortin-4 receptor agonists |
09/26/2002 | CA2441162A1 Pharmaceutical composition comprising, as an active ingredient, triazaspiro[5.5]undecane derivative |
09/26/2002 | CA2440954A1 Phenyl derivatives 3 |
09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
09/26/2002 | CA2440405A1 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
09/26/2002 | CA2440264A1 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
09/25/2002 | EP1243589A1 Heteroaryl-substituted pyrrole derivates, their preparation and their therapeutic uses |
09/25/2002 | EP1243583A1 Heterocyclic compounds having sulfonamide groups |
09/25/2002 | EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use |
09/25/2002 | EP1242420A2 Agents and methods for the treatment of proliferative diseases |
09/25/2002 | EP1242413A1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels |
09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
09/25/2002 | EP1242075A2 Indole compounds |
09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
09/25/2002 | EP0931081B1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
09/25/2002 | EP0925299B1 Pyrazolopyridine compound and pharmaceutical use thereof |
09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
09/25/2002 | EP0835257B1 Intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
09/25/2002 | EP0746556B1 Tricyclic compounds having affinity for the 5-ht1a receptor |
09/25/2002 | CN1371377A Method for producing triethylene diamine, using ethylene diamine |
09/25/2002 | CN1371374A Substituted heterocycle fused gamma-carbolines |
09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
09/25/2002 | CN1370778A Beta-tetrahydro carboline carboxylic acid, its RGD conjugate, their synthesis and medical application |
09/24/2002 | US6455699 Camptothecin analogs and methods of preparation thereof |
09/24/2002 | US6455564 Oral administration of (5r)-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinolin-2( '1h)-one or -thione |
09/24/2002 | US6455539 Autoimmune disease; antiinflammatory agents; antiproliferatory agents |
09/24/2002 | US6455538 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols |
09/24/2002 | US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
09/24/2002 | US6455527 High affinity ligands for nociceptin receptor ORL-1 |
09/24/2002 | US6455523 Inhibitors of farnesyl protein transferase |
09/24/2002 | CA2358003C Photodynamic plant defoliants and chlorophyll biosynthesis modulators |
09/19/2002 | WO2002072585A2 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
09/19/2002 | WO2002072582A1 Methods for the synthesis of densely functionalized pyrrolidine template libraries |
09/19/2002 | WO2002072581A2 Pyrazolopyriadine derivatives |
09/19/2002 | WO2002072580A1 Preventives and/or remedies for kidney diseases and kidney failure |
09/19/2002 | WO2002072579A1 Triazolopyridines as anti-inflammatory agents |
09/19/2002 | WO2002072547A1 Amination process |
09/19/2002 | WO2002072511A1 'convenient and efficient suzuki-miyaura cross-coupling catalyzed by a palladium/diazabutadiene system' |
09/19/2002 | WO2002072109A1 Substituted 3',4'-di-o-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof |
09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
09/19/2002 | WO2002053534A8 Vla-4 inhibitors |
09/19/2002 | WO2002036123A3 New treatments for restless legs syndrome |
09/19/2002 | WO2002024695A3 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
09/19/2002 | WO2002014311A3 Urea compounds and methods of uses |
09/19/2002 | WO2001016139A9 Androgen receptor modulator compounds and methods |
09/19/2002 | US20020133023 Antitumor agents, osteoporosis |